Literature DB >> 9049660

T lymphocytes subsets in experimental iron overload.

J E Cardier1, E Romano, A Soyano.   

Abstract

Several abnormalities of the immune system have been reported in association with clinical and experimental iron overload. To dissect further such abnormalities, changes in lymphocyte subsets were evaluated in iron-loaded male Sprague-Dawley rats. The iron-loading protocol consisted of a total dose of irondextran (1.5 mg/Kg body weight) divided in daily intramuscular injections over twenty consecutive days. At days 0, 20, and 50 after initiation of iron injections lymphocyte subsets in blood, spleen and mesenteric lymph nodes were estimated by indirect immunofluorescence using monoclonal antibodies recognizing T cells (W3.13), the subset of helper T cells in (W3.25), and the subset of cytotoxic T cells (OX.8). By day 20, there was no change in the number of W3.25+ T cells in the blood of iron-loaded animals as compared to the controls, but the OX.8+ T cells were significantly elevated. At this time, the ratio W3.25 +/OX.8+ cells was significantly decreased (0.5 in experimental rats vs 2.0 in controls). Similar results were obtained at day 50. In the spleen, there was a decrease in the proportion of W3.25 +T cells and an increase in OX.8+ T cells at day 20. However, these values returned to normal by day 50. A negative correlation between W3.25 +/OX.8+ ratio and serum ferritin was observed in blood and spleen during iron administration. These changes were associated with abnormalities in lymphocyte proliferative response. No changes in W3.25 +/OX.8+ ratio were observed in mesenteric lymph nodes. These results demonstrate that iron overload alters the distribution of T lymphocytes in various compartments of the immune system.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9049660     DOI: 10.3109/08923979709038534

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  4 in total

1.  Pterins as sensors of response to the application of Fe3+ -dextran in piglets.

Authors:  Miriam Smutna; Martin Svoboda; Klara Breinekova
Journal:  Sensors (Basel)       Date:  2010-01-22       Impact factor: 3.576

Review 2.  Al-hijamah and oral honey for treating thalassemia, conditions of iron overload, and hyperferremia: toward improving the therapeutic outcomes.

Authors:  Salah Mohamed El Sayed; Hussam Baghdadi; Ashraf Abou-Taleb; Hany Salah Mahmoud; Reham A Maria; Nagwa S Ahmed; Manal Mohamed Helmy Nabo
Journal:  J Blood Med       Date:  2014-10-30

3.  The novel SLC40A1 (T419I) variant results in a loss-of-function phenotype and may provide insights into the mechanism of large granular lymphocytic leukemia and pure red cell aplasia.

Authors:  Hongfei Wu; Xiang Ren; Meili Ge; Peiyuan Dong; Shichong Wang; Huiming Yi; Xingxin Li; Jiali Huo; Xuan Zheng; Mengying Gao; Jinbo Huang; Jing Zhang; Min Wang; Peng Jin; Neng Nie; Yingqi Shao; Yizhou Zheng
Journal:  Blood Sci       Date:  2021-12-06

Review 4.  Oxidative stress and age-related changes in T cells: is thalassemia a model of accelerated immune system aging?

Authors:  Mahdi Ghatreh-Samani; Nafiseh Esmaeili; Masoud Soleimani; Majid Asadi-Samani; Keihan Ghatreh-Samani; Hedayatolah Shirzad
Journal:  Cent Eur J Immunol       Date:  2016-01-20       Impact factor: 2.085

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.